Positron emission tomography detection of osseous metastases of renal cell carcinoma not identified on bone scan

Eugene Seto, George M. Segall, Martha Kennedy Terris

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

The clinical utility of positron emission tomography (PET) in renal cell carcinoma (RCC) has not been determined. We describe a case in which metastatic RCC undetected by traditional staging methods was accurately staged by PET. A 77-year-old man presented with a 20-lb weight loss and bilateral renal masses. Plain radiographs, bone scintigraphy, and alkaline phosphatase were normal. PET imaging confirmed the right renal mass and revealed several metastatic bone lesions, confirmed by biopsy. The patient died 7 months after diagnosis. This case illustrates the potential superiority of PET in evaluating skeletal metastases of RCC. (C) 2000, Elsevier Science Inc.

Original languageEnglish (US)
Number of pages1
JournalUrology
Volume55
Issue number2
StatePublished - Jan 1 2000
Externally publishedYes

Fingerprint

Renal Cell Carcinoma
Positron-Emission Tomography
Neoplasm Metastasis
Bone and Bones
Kidney
Radionuclide Imaging
Alkaline Phosphatase
Weight Loss
Biopsy

ASJC Scopus subject areas

  • Urology

Cite this

Positron emission tomography detection of osseous metastases of renal cell carcinoma not identified on bone scan. / Seto, Eugene; Segall, George M.; Terris, Martha Kennedy.

In: Urology, Vol. 55, No. 2, 01.01.2000.

Research output: Contribution to journalArticle

@article{83442512b8dc49d9bdfa8c3fae57a254,
title = "Positron emission tomography detection of osseous metastases of renal cell carcinoma not identified on bone scan",
abstract = "The clinical utility of positron emission tomography (PET) in renal cell carcinoma (RCC) has not been determined. We describe a case in which metastatic RCC undetected by traditional staging methods was accurately staged by PET. A 77-year-old man presented with a 20-lb weight loss and bilateral renal masses. Plain radiographs, bone scintigraphy, and alkaline phosphatase were normal. PET imaging confirmed the right renal mass and revealed several metastatic bone lesions, confirmed by biopsy. The patient died 7 months after diagnosis. This case illustrates the potential superiority of PET in evaluating skeletal metastases of RCC. (C) 2000, Elsevier Science Inc.",
author = "Eugene Seto and Segall, {George M.} and Terris, {Martha Kennedy}",
year = "2000",
month = "1",
day = "1",
language = "English (US)",
volume = "55",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Positron emission tomography detection of osseous metastases of renal cell carcinoma not identified on bone scan

AU - Seto, Eugene

AU - Segall, George M.

AU - Terris, Martha Kennedy

PY - 2000/1/1

Y1 - 2000/1/1

N2 - The clinical utility of positron emission tomography (PET) in renal cell carcinoma (RCC) has not been determined. We describe a case in which metastatic RCC undetected by traditional staging methods was accurately staged by PET. A 77-year-old man presented with a 20-lb weight loss and bilateral renal masses. Plain radiographs, bone scintigraphy, and alkaline phosphatase were normal. PET imaging confirmed the right renal mass and revealed several metastatic bone lesions, confirmed by biopsy. The patient died 7 months after diagnosis. This case illustrates the potential superiority of PET in evaluating skeletal metastases of RCC. (C) 2000, Elsevier Science Inc.

AB - The clinical utility of positron emission tomography (PET) in renal cell carcinoma (RCC) has not been determined. We describe a case in which metastatic RCC undetected by traditional staging methods was accurately staged by PET. A 77-year-old man presented with a 20-lb weight loss and bilateral renal masses. Plain radiographs, bone scintigraphy, and alkaline phosphatase were normal. PET imaging confirmed the right renal mass and revealed several metastatic bone lesions, confirmed by biopsy. The patient died 7 months after diagnosis. This case illustrates the potential superiority of PET in evaluating skeletal metastases of RCC. (C) 2000, Elsevier Science Inc.

UR - http://www.scopus.com/inward/record.url?scp=0343851662&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0343851662&partnerID=8YFLogxK

M3 - Article

VL - 55

JO - Urology

JF - Urology

SN - 0090-4295

IS - 2

ER -